Inspire obtains milestone payment from Santen

pharmaceutical-business-review.com     May 17, 2008            

Inspire Pharmaceuticals has received $1.25 million milestone payment from Santen Pharmaceutical, related to the completion of Santen's Phase III testing of diquafosol tetrasodium, for the treatment of dry eye. Santen has announced that it expects to file an application by the end of June 2008 for... [read full story]                

Add a comment to the article
Type the code shown

View all news articles about:

- Companies